Art. 70 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 12×
1.

When a marketing authorization is granted, the competent authorities shall specify the classification of the medicinal product into:

a medicinal product subject to medical prescription,

a medicinal product not subject to medical prescription.

To this end, the criteria laid down in Article 71(1) shall apply.

2.

The competent authorities may fix sub-categories for medicinal products which are available on medical prescription only. In that case, they shall refer to the following classification:

(a)

medicinal products on medical prescription for renewable or non-renewable delivery;

(b)

medicinal products subject to special medical prescription;

(c)

medicinal products on ‘restricted’ medical prescription, reserved for use in certain specialised areas.

The 10 that are cited most themselves, of 12.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…14Law

    … или употреба на лекарствените продукти в съответствие с член 70, параграф 1 от Директива 2001/83/ЕО. 11. Без това да засяга …

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision

    Regarding the context of which Article 96(1) of Directive 2001/83 forms part, it is important in particular to highlight that Article 70(1) of that directive provides that, when they grant a marketing authorisation of a medicinal product, …

    11 Jun 2020 · 62018CJ0786

  • Judgment of the Court (Fifth Chamber) of 18 September 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egDecision

    Title VI of that directive, entitled ‘Classification of Medicinal Products’, includes Articles 70 to 75 of the directive. Article 70 provides: ‘1. When a marketing authorisation is granted, the competent authorities shall specify the …

    18 Sep 2019 · 62018CJ0222

  • Opinion of Advocate General Szpunar delivered on 20 May 2021. Pharma Expressz Szolgáltató és Kereskedelmi Kft v Országos Gyógyszerészeti és Decision

    In those circumstances, by decision of 10 March 2020, received at the Court on 7 April 2020, the Fővárosi Törvényszék (formerly the Fővárosi Közigazgatási és Munkaügyi Bíróság) (Budapest High Court, formerly Budapest …

    20 May 2021 · 62020CC0178

  • Opinion of Advocate General Bot delivered on 12 June 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egéDecision

    The referring court states that it has difficulty in determining whether the Hungarian legislation in question is compatible with the concept of ‘prescription’ as defined in EU law and with the rule that medical prescriptions should be …

    12 Jun 2019 · 62018CC0222

  • Judgment of the Court (Fourth Chamber) of 8 July 2021. Pharma Expressz Szolgáltató és Kereskedelmi Kft v Országos Gyógyszerészeti és ÉlelmezDecisioninterprets

    In those circumstances the Fővárosi Törvényszék (Budapest High Court) decided to stay the proceedings and to refer the following questions to the Court of Justice for a preliminary ruling: Does an obligation flow from Articles 70 to …

    8 Jul 2021 · 62020CJ0178

  • BGH, Urteil vom 17. Dezember 2020 - I ZR 235/16Decision

    c) Aus der in Art. 70 Abs. 1, Art. 71 Abs. 1 und Art. 72 der Richtlinie 2001/83/EG getroffenen Unterscheidung zwischen den der ärztlichen Verschreibungspflicht unterliegenden und der Verschreibungspflicht nicht unterliegenden …

    17 Dec 2020 · KORE303752021

  • Judgment of the General Court (Tenth Chamber, Extended Composition) of 13 November 2024. Orion Oyj v European Commission.Decision

    In the course of examining the application for marketing authorisation for Dexmedetomidine Accord, the EMA sent, on 30 November 2018, an email to the SUKL requesting from it certain information concerning the Czech marketing authorisation …

    13 Nov 2024 · 62020TJ0223

  • Conseil d'État, 1ère et 4ème chambres réunies, 8 avril 2024, n° 470279, mentionné aux tables du recueil LebonDecision

    … de mise sur le marché centralisée, de déterminer les conditions de prescription du médicament au titre de l'article 70 de la directive 2001/83/CE du Parlement européen et du Conseil du 6 novembre 2001 et, à ce titre, de décider le …

    8 Apr 2024 · DCE_470279_20240408